{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:13:56Z","timestamp":1790118836652,"version":"4.0.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1985,12,1]],"date-time":"1985-12-01T00:00:00Z","timestamp":502243200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[1985,12]]},"DOI":"10.1007\/bf00313833","type":"journal-article","created":{"date-parts":[[2004,10,10]],"date-time":"2004-10-10T17:39:51Z","timestamp":1097429991000},"page":"346-351","source":"Crossref","is-referenced-by-count":49,"title":["Somatostatin-like immunoreactivity and substance-P-like immunoreactivity in the CSF of patients with senile dementia of Alzheimer type, multi-infarct syndrome and communicating hydrocephalus"],"prefix":"10.1007","volume":"232","author":[{"given":"H.","family":"Cramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Schaudt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Rissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Strubel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Warter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Kuntzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"CR1","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJM196507152730301","volume":"273","author":"RD Adams","year":"1965","unstructured":"Adams RD, Fisher CM, Hakim S, Ojeman RG, Sweet HW (1965) Symptomatic occult hydrocephalus with ?normal? cerebrospinal fluid pressure. N Engl J Med 273:117?126","journal-title":"N Engl J Med"},{"key":"CR2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/0022-510X(84)90180-1","volume":"64","author":"JM Allen","year":"1984","unstructured":"Allen JM, Ferrier IN, Roberts GW, Gross AJ, Adrian TE, Crow TJ, Bloom SR (1984) Elevation of neuropeptide Y (NPY) in substantia innominata in Alzheimer's type of dementia. J Neurol Sci 64:325?331","journal-title":"J Neurol Sci"},{"key":"CR3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.3181\/00379727-148-38631","volume":"148","author":"A Arimura","year":"1975","unstructured":"Arimura A, Sato H, Coy DH, Schally A (1975) Radioimmunoassay for GH-release inhibiting hormone. Proc Soc Exp Biol Med 148:784?789","journal-title":"Proc Soc Exp Biol Med"},{"key":"CR4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0167-0115(81)90048-3","volume":"1","author":"P Brazeau","year":"1981","unstructured":"Brazeau P, Ling N, Esch F, B\u00f6hlen P, Benoit R, Guillemin R (1981) High biological activity of the synthetic replicates of somatostatin-28 and somatostatin-25. Regul Pept 1:255?264","journal-title":"Regul Pept"},{"key":"CR5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1210\/endo-96-6-1456","volume":"96","author":"M Brownstein","year":"1975","unstructured":"Brownstein M, Arimura A, Sato H, Schally AV, Kizer JS (1975) The regional distribution of somatostatin in the rat brain. Endocrinology 96:1456?1461","journal-title":"Endocrinology"},{"key":"CR6","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/BF00313783","volume":"232","author":"H Cramer","year":"1985","unstructured":"Cramer H, Wolf A, Rissler K, Weigel K, Ostertag Ch (1985) Ventricular somatostatin-like immunoreactivity in patients with basal ganglia disease. J Neurol 232:219?222","journal-title":"J Neurol"},{"key":"CR7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1136\/bmj.282.6258.93","volume":"282","author":"AJ Cross","year":"1981","unstructured":"Cross AJ, Crow TJ, Perry EK, Perry RH, Blessed G, Tomlinson BE (1981) Reduced dopamine-beta-hydroxylase activity in Alzheimer's disease. Br Med J 282:93?94","journal-title":"Br Med J"},{"key":"CR8","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1111\/j.1471-4159.1982.tb06665.x","volume":"38","author":"HA Crystal","year":"1982","unstructured":"Crystal HA, Davies P (1982) Cortical substance P-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. J Neurochem 38:1781?1784","journal-title":"J Neurochem"},{"key":"CR9","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/0006-8993(79)90336-6","volume":"171","author":"P Davies","year":"1979","unstructured":"Davies P (1979) Neurotransmitter-related enzymes in senile dementia of Alzheimer's type. Brain Res 171:319?327","journal-title":"Brain Res"},{"key":"CR10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/0197-4580(81)90053-1","volume":"2","author":"P Davies","year":"1980","unstructured":"Davies P, Terry RD (1980) Cortical somatostatin-like immunoreactivity in cases of Alzheimer's disease and senile dementia of the Alzheimer type. Neurobiol Aging 2:9?14","journal-title":"Neurobiol Aging"},{"key":"CR11","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0006-291X(85)90604-7","volume":"126","author":"D Dawbarn","year":"1985","unstructured":"Dawbarn D, Emson PC (1985) Neuropeptide Y-like immunoreactivity in neuritic plaques of Alzheimer disease. Biochem Biophys Res Commun 126:298?294","journal-title":"Biochem Biophys Res Commun"},{"key":"CR12","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/273674a0","volume":"273","author":"J Dodd","year":"1978","unstructured":"Dodd J, Kelly JS (1978) Is somatostatin an excitatory transmitter in the hippocampus? Nature 273:674?675","journal-title":"Nature"},{"key":"CR13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1212\/WNL.32.3.312","volume":"32","author":"E Dupont","year":"1982","unstructured":"Dupont E, Christensen SE, Hansen AaP, Olivarius BF, Orskov H (1982) Low cerebrospinal fluid somatostatin in Parkinson's disease: an irreversible abnormality. Neurology (NY) 32:312?314","journal-title":"Neurology"},{"key":"CR14","doi-asserted-by":"crossref","unstructured":"Gattaz WF, Rissler K, Gattaz D, Cramer H (1985) Haloperidol increases somatostatin-like immunoreactivity in the CSF of schizophrenic patients. Psychiatry Res (in press)","DOI":"10.1016\/0165-1781(86)90035-1"},{"key":"CR15","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/j.1471-4159.1969.tb05984.x","volume":"16","author":"CG Gottfries","year":"1969","unstructured":"Gottfries CG, Gottfries I, Roos BE (1969) Homovanillic acid and 5-hydroxyindoleacetic acid in the cerebrospinal fluid of patients with senile dementia, presenile dementia and parkinsonism. J Neurochem 16:1341?1345","journal-title":"J Neurochem"},{"key":"CR16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1042\/bj0890114","volume":"89","author":"FC Greenwood","year":"1963","unstructured":"Greenwood FC, Hunter WM, Glover JS (1963) The preparation of 131J-labelled human growth hormone of high specific radioactivity. Biochem J 89:114?120","journal-title":"Biochem J"},{"key":"CR17","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1210\/endo-99-6-1653","volume":"99","author":"R Guillemin","year":"1976","unstructured":"Guillemin R (1976) Somatostatin inhibits the release of acetylcholine induced electrically in the myenteric plexus. Endocrinology 99:1633?1654","journal-title":"Endocrinology"},{"key":"CR18","first-page":"97","volume":"7","author":"V Hachinski","year":"1978","unstructured":"Hachinski V (1978) Cerebral blood flow: differentiation of Alzheimer's disease from multi-infarct dementia. Aging 7:97?103","journal-title":"Aging"},{"key":"CR19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/0006-8993(78)90425-0","volume":"153","author":"S Ioffe","year":"1978","unstructured":"Ioffe S, Havlicek V, Friesen H, Chernick V (1978) Effect of somatostatin (SRIF) and L-glutamate in neurons of the sensorimotor cortex in awake habituated rabbits. Brain Res 153:414?418","journal-title":"Brain Res"},{"key":"CR20","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/BF00343993","volume":"231","author":"J Kohler","year":"1982","unstructured":"Kohler J, Schr\u00f6ter E, Cramer H (1982) Somatostatin-like immunoreactivity in the cerebrospinal fluid of neurological patients. Arch Psychiatr Nervenkr 231:503?508","journal-title":"Arch Psychiatr Nervenkr"},{"key":"CR21","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1212\/WNL.34.6.741","volume":"34","author":"PL McGeer","year":"1984","unstructured":"McGeer PL, McGeer EG, Suzuki J, Dolman CE, Nagai T (1984) Aging, Alzheimer's disease and the cholinergic system of the basal forebrain. Neurology (Cleveland) 34:741?745","journal-title":"Neurology"},{"key":"CR22","doi-asserted-by":"crossref","first-page":"6171","DOI":"10.1073\/pnas.77.10.6171","volume":"77","author":"CA Meyers","year":"1980","unstructured":"Meyers CA, Murphy WA, Redding TW, Coy DH, Schally AV (1980) Synthesis and biological actions of prosomatostatin. Proc Natl Acad Sci USA 77:6171?6174","journal-title":"Proc Natl Acad Sci USA"},{"key":"CR23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/0006-8993(83)91031-4","volume":"262","author":"JH Morrison","year":"1983","unstructured":"Morrison JH, Benoit R, Magistretti PJ, Bloom FE (1983) Immunohistochemical distribution of pro-somatostatin-related peptides in cerebral cortex. Brain Res 262:344?351","journal-title":"Brain Res"},{"key":"CR24","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/314090a0","volume":"314","author":"JH Morrison","year":"1985","unstructured":"Morrison JH, Rogers J, Scherr St, Benoit R, Bloom FE (1985) Somatostatin immunoreactivity in neuritic plaques of Alzheimer's patients. Nature 314:90?92","journal-title":"Nature"},{"key":"CR25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1159\/000212476","volume":"27","author":"JJ Oram","year":"1981","unstructured":"Oram JJ, Edwardson J, Millard PH (1981) Investigation of cerebrospinal fluid neuropeptides in idiopathic senile dementia. Gerontology 27:216?223","journal-title":"Gerontology"},{"key":"CR26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0166-2236(83)90147-9","volume":"6","author":"M Otsuka","year":"1983","unstructured":"Otsuka M, Konishi S (1983) Substance P?the first peptide neurotransmitter? Trends Neurol Sci 6:317?320","journal-title":"Trends Neurol Sci"},{"key":"CR27","first-page":"3","volume-title":"Physiological peptides and new trends in radio-immunology","author":"E Penman","year":"1981","unstructured":"Penman E, Wass JAH (1981) Radioimmunoassay of somatostatin: methodological problems and physiological investigations. In: Bizollon CA (ed) Physiological peptides and new trends in radio-immunology. Elsevier-North Holland Biomedical Press, The Hague, pp 3?18"},{"key":"CR28","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0022-510X(81)90123-4","volume":"51","author":"RH Perry","year":"1981","unstructured":"Perry RH, Dockray GJ, Dimaline R, Perry EK, Blessed G, Tomlinson BE (1981) Neuropeptides in Alzheimer's disease, depression and schizophrenia. J Neurol Sci 51:465?472","journal-title":"J Neurol Sci"},{"key":"CR29","first-page":"21","volume-title":"Proceedings of the 2nd International Symposium on Somatostatin","author":"S Reichlin","year":"1984","unstructured":"Reichlin S, Robbins R, Lechan R (1984) Somatostatin and the nervous system. In: Raptis S, Rosenthal J, Gerich JE (eds) Proceedings of the 2nd International Symposium on Somatostatin. Attempto Verlag, T\u00fcbingen, pp 21?37"},{"key":"CR30","first-page":"702","volume":"19","author":"B Reisberg","year":"1983","unstructured":"Reisberg B, London E, Ferris SH, Borenstein J, Scheier L, de Leon MJ (1983) The brief cognitive rating scale: language, motoric and mood concomitants in primary degenerative dementia. Psychopharmacol Bull 19:702?708","journal-title":"Psychopharmacol Bull"},{"key":"CR31","first-page":"573","volume-title":"The role of peptides in neuronal function","author":"OP Rorstadt","year":"1980","unstructured":"Rorstadt OP, Martin JB (1980) Somatostatin and the nervous system. In: Barker JL, Smith TG Jr (eds) The role of peptides in neuronal function. Marcel Dekker, New York, pp 573?613"},{"key":"CR32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0166-2236(82)90222-3","volume":"4","author":"MN Rossor","year":"1982","unstructured":"Rossor MN, Emson PC (1982) Neuropeptides in degenerative disease of the central nervous system. Trends Neurol Sci 4:399?401","journal-title":"Trends Neurol Sci"},{"key":"CR33","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0304-3940(80)90177-9","volume":"20","author":"MN Rossor","year":"1980","unstructured":"Rossor MN, Emson PC, Mountjay CQ, Roth M, Iversen LL (1980) Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type. Neurosci Lett 20:373?377","journal-title":"Neurosci Lett"},{"key":"CR34","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1600-0404.1981.tb04392.x","volume":"64","author":"H Soininen","year":"1981","unstructured":"Soininen H, MacDonald E, Rekonen M, Riekkinen PJ (1981) Homovanillic acid 5-hydroxy-indoleacetic acid levels in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Acta Neurol Scand 64:101?107","journal-title":"Acta Neurol Scand"},{"key":"CR35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0022-510X(84)90193-X","volume":"63","author":"H Soininen","year":"1984","unstructured":"Soininen H, Jolkkonen JT, Keinikainen KJ, Halonen TO, Riekkinen PJ (1984) Reduced cholinesterase activity and somatostatin-like immunoreactivity in the cerebrospinal fluid of patients with dementia of the Alzheimer type. J Neurol Sci 63:167?172","journal-title":"J Neurol Sci"},{"key":"CR36","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1146\/annurev.ne.03.030180.000453","volume":"3","author":"RD Terry","year":"1980","unstructured":"Terry RD, Davies P (1980) Dementia of the Alzheimer type. Ann Rev Neurosci 3:77?95","journal-title":"Ann Rev Neurosci"},{"key":"CR37","first-page":"25","volume-title":"Aeging and dementia","author":"BE Tomlinson","year":"1977","unstructured":"Tomlinson BE (1977) Morphological changes and dementias in old age. In: Smith WL, Kinsbourne M (eds) Aeging and dementia. Spectrum, New York, pp 25?56"},{"key":"CR38","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/0024-3205(82)90099-6","volume":"31","author":"PL Wood","year":"1982","unstructured":"Wood PL, Etienne P, Lal S, Gauthier S, Cajal S, Nair NP (1982) Reduced lumbar CSF somatostatin in Alzheimer's disease. Life Sci 31:2073?2079","journal-title":"Life Sci"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00313833.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF00313833\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF00313833","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,3]],"date-time":"2020-04-03T09:45:07Z","timestamp":1585907107000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF00313833"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1985,12]]},"references-count":38,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1985,12]]}},"alternative-id":["BF00313833"],"URL":"https:\/\/doi.org\/10.1007\/bf00313833","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[1985,12]]}}}